Hepatitis A seroepidemiology in Eastern Turkey

East African Medical Journal

Volumn 83, Issue 2, 2006, Pages 86-90

  Vancelik, S ^a,b   Guraksin, A ^a   Alp, H ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646475172     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v83i2.9393     Document Type: Article

References (33)

1. Snyder J.D., and Pickering L.K. Hepatitis A through E. In: Bohrman R.E., Kliegman, Arvin M.A., (eds). Nelson Textbook of pediatrics. 1996, pp: 909-911.
2. Dienstag J.L., Szmunees S.V., Stevens C.E., et al. Hepatitis A virus infection. New insights from seroepidemiologic studies. J. Infectious Dis. 1978; 137: 328-340.
3. Koff R.S. Seroepidemiology of hepatitis A in the USA J. infect Dis. 1995; 171: 19-23.
4. Steven D.M. Who should receive hepatitis A vaccine? Cleveland Clinic J. Med. 2001; 68; 10: 825-827.
5. th edition, pp: 131-133.
6. Coulehan J.I., Eberhard S., Kapner L. et al. Vitamin C and acute illness in Navaj schoolchildren. N. Engl. J. Med. 1996; 295: 973.
7. Hendley J.O., Edmondson W.P. Jr., and Gwaltney J.M. Jr. Relationship between naturally acquired immunity and infectivity of two rhinoviruses in volunteers. J. Infect Dis. 1972; 125: 243.
8. Badur S. Status of Viral Hepatitis in Turkey. Kiliç Turgay K (ed). Viral Hepatitis 1994. Istanbul: Nobel Medicine Publishing House, 1994; pp: 15-37.
9. Uzunalimoglu Ö., Özden A., Kesim E. and all. Hepatitis A epidemiology in Turkey. 10. Turkey Gastroenterology Congress, Bursa, 1993, pp: 330.
10. Vaughan J.P., and Morrow R.H. Manual of Epidemiology for District Health Management. World Health Organization: Geneva, 1989, pp: 78-80.
11. Dentinger C.M., Heinrich N.I., Bell B.P., Fox L.M. et al. A prevalence study of hepatitis A virus infection in a migrant community: Is hepatitis A vaccine indicated? J. Pediatr. 2001; 138: 705-912.
12. Barros H., Oliveria F., and Miranda H. A survey on hepatitis in Portuguese children and adolescents. J. Viral Hepatitis. 1999; 6: 249-253.
13. Assis S.B., Souto F.J., Fontes C.J., et al. Prevalence of antibodies to hepatitis A and E infection in school children of an Amazonian Municipality in Matograsso State. Rev. Soc. bras. Med. Trop. 2002; 35: 155-158.
14. Kanra G., Tezcan S., and Badur S. The prevalence of hepatitis A and varicella antibodies in the Turkish population, study report. 1998-1999; pp: 3,21
15. Sidal M., Unuvar E., Oguz E., et al. Age-specific seroepidemiology of hepatit A, B, and E infections among children in Istanbul, Turkey. Eur. J. Epidemiol. 2001; 17: 141-144.
16. Sahin M.K., Yarkin E., Kocabas E., et al. The research of HAV, HBV and HCV markers in children. Turkish J. Viral Hepatitis. 1998; 2: 104-108.
17. Baki A., Köksal Ï., Aynaci M., et al. Hepatitis A prevalence in Trabzon, Turkey, children. Doga Turk. J. Med. Sci. 1992; 16: 206-209.
18. Akgün N., Koçak A., Tekin N., et al. HAV and HBV infection prevalence among children. XXI. Congres of UMEMPS, Izmir in Türkey. Abstract Book. pp: 55.
19. Aribas E.T., Altindis M., Koc H., et al. Hepatitis A and hepatitis E seroprevalence among children in Konya, in Turkey. J. Child Health. 1999; 42: 505-511.
20. The East Anatolia Project director summary book. Turkey Republic of Prime Minister of the state planning organization. Ankara. 2000, pp: 1-2.
21. Wu J.S., Lu C.E., Wu L.Z., Wong C.K., et al. Changing seroepidemiology of hepatitis A virus infection between two regions in Taiwan differing in socio-economic status. J. Farmos Med. Assoc. 1993; 92: 812-815.
22. Amin J., Gilbert G.L., Escott R.G., et al. Hepatitis A epidemiology in Australia: National seroprevalence and notifications. Med. J. Aust. 2001; 174: 338-341.
23. Mall ML, Rai R.R., Philip M., et al. Seroepidemiology of hepatitis A infection in India: changing pattern. Indian J. Gastroenterol. 2002; 21: 132-135.
24. Atabek M.E., Ural O., and Coban H. Hepatitis A, B and hepatitis E seroprevalence among children in Konya, in Turkey. J. Child Health. 2001; 44: 66-70.
25. Aldeniz C., Çavuslu S., Altunay H., et al. Hepatitis A and hepatitis E seroprevalence among children in Istanbul. J. Viral Hepatitis of Turkey. 1998; 1: 31-36.
26. Antaki H., and Kebbewar M.K. Hepatitis A seroprevalence rate in Syria. Trop. Doct. 2000; 30: 99-101.
27. Termorshizen F., Dorigo - Zetsma J.W., de melker H.E., van den Hof S., Conyn et al. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infect. 2000; 124: 459-466.
28. Akbar S.M., Onji M., Kanaoka M., Horiike H. et al. The seroepidemiology of hepatitis O and B in a Japanese Town. Asia Pac. J. Public Health. 1992-1993; 6: 26-29.
29. Chin K.P., Lok A.S., Wong L.S., et al. Current seroepidemiology of hepatitis A. Hong Kong J. Med. Virol. 1991; 34: 191-193.
30. Almeida L.M., Werneck G.L., Cairncross S., et al. The epidemiology of hepatitis A in Rio de Janeiro: Environmental and domestic risk factors. Epidemiol Infect. 2001; 127: 327-333.
31. Arankalle V.A., Chadha M.S., Chitambar S.D., et al. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). J. Viral Hepat. 2001; 8: 293.
32. Strofpolini T., Chiaramonte M., Eranco E., et al. Seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection. 1991; 19: 97-100.
33. Notice readers: recommended childhood immunisation Schedule-United States 2000. MMWR 2001; 50: 7-10.